Best Lymphoma chemotherapy doctors in Turkey: TOP 28 doctors

Dr. Solak completed advanced training in oncology at Hacettepe University Cancer Institute, one of Turkey's leading cancer centers.

• Specializes in chemotherapy for various cancers, including lymphoma
• Fellowship-trained at The University of Texas MD Anderson Cancer Center
• Extensive experience treating head and neck cancers
• Works at Hisar Hospital Intercontinental – equipped with modern facilities

Professor Alp Özkan is one of Turkey's top lymphoma specialists, with 20+ years focused on pediatric oncology. He leads the Pediatric Oncology Department at Anadolu Medical Center.

• Trained at Istanbul University and MD Anderson Cancer Hospital in the USA
• Published 70+ scientific articles on childhood cancer
• Author of 5 books on pediatric hematology oncology
• Recipient of the Turkish Scientific Prize in Pediatric Oncology

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas

Bone marrow transplantation

Assoc. Prof. Dr. Oguzhan Babacan specializes in pediatric lymphoma treatment and has 13 years of experience in bone marrow transplantation at Hisar Hospital Intercontinental.

• Subspecialty trained in Pediatric Hematology and Oncology
• Expert in allogeneic, autologous, and haploidentical stem cell transplants
• Focuses on leukemia, lymphoma, and solid tumors in children
• Associate Professor in Pediatric Hematology and Oncology

Professor Bulent Eser specializes in lymphoma chemotherapy at Medical Park Antalya Hospital Complex, with over 20 years of hematology experience.

• Professor of Internal Medicine/Hematology at Erciyes University
• Member of the European Group for Blood and Marrow Transplantation
• Extensive research and academic background in hematology
• Part of the Turkish Society of Hematology

Specializes in lymphoma chemotherapy with extensive training at Akdeniz University – one of Turkey's leading medical schools.

• Board-certified in medical oncology since 2018
• Over 15 years of experience in internal medicine and oncology
• Worked at multiple university hospitals including Akdeniz University Hospital
• Currently practices at Medical Park Antalya Hospital Complex

Dr. Sevindik trained at Mayo Clinic and specializes in lymphoma chemotherapy at Istanbul Florence Nightingale Hospital.

• Board-certified in hematology with 9 years of experience
• Published 18 articles in international peer-reviewed journals
• Former faculty member at Medipol University Hospital
• Expertise in both national and international treatment protocols

Prof. Bozkurt specializes in pediatric lymphoma chemotherapy with over 20 years of experience at top hospitals like Medical Park Bahcelievler.

• Trained at Cincinnati Children's Hospital and Harvard's Dana-Farber Cancer Institute
• Vice Director of Stem Cell Transplant Unit with expertise in bone marrow transplants
• Published 40+ peer-reviewed articles on pediatric oncology
• Member of European Bone Marrow Transplant Group

Specializing in pediatric hematology and oncology, Dr. Yaman focuses on lymphoma chemotherapy.

• Dedicated to treating children with hematologic conditions
• Works at Medipol Mega University Hospital
• Expertise in pediatric oncology treatments

Dr. Akdeniz brings extensive training in thoracic and cardiovascular surgery, with experience at leading hospitals in Turkey.

• Trained at Siyami Ersek Thoracic and Cardiovascular Surgery Hospital
• Completed medical education at Istanbul Faculty of Medicine
• Worked at M. Akif Ersoy Thoracic and Cardiovascular Surgery Hospital

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Experience in oncology departments across multiple hospitals in Turkey
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Professor of Medical Oncology at Trakya University – Dr. Cicin specializes in lymphoma chemotherapy with 20+ years of experience.

• Fellowship-trained in Medical Oncology at Trakya University
• Former Associate Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Assoc. Prof. Atakan Topcu combines expertise in targeted lymphoma therapies with research on cancer-related malnutrition at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology journals
• Special focus on geriatric lymphoma patients and immunotherapy
• Member of European Society for Medical Oncology (ESMO)
• Medical oncology fellowship at Bezmialem Vakıf University

Dr. Metin Demirkaya is a specialist in Pediatric Oncology. He earned his medical degree from Istanbul University Cerrahpaşa School of Medicine between 1993 and 1999. He completed his Pediatrics residency and Pediatric Oncology residency at Bursa Uludag University from 1999 to 2010.

Dr. Demirkaya has worked at leading centers such as GATA Pediatric Hematology-Oncology-Bone Marrow Transplantation Centre and Istanbul Kanuni Sultan Süleyman Education and Research Hospital. He became an Assistant Professor in 2013. In 2019, he was appointed Professor of Medicine in Pediatric Oncology at Medicana Bursa Hospital.

Dr. Demirkaya is known for his clinical skills and leadership in pediatric cancer care and bone marrow transplantation. He has made important contributions to research and has received recognition in his field.

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Prof. Dr. Sebnem Izmir Guner founded multiple hematology centers and specializes in lymphoma treatment at Hisar Hospital Intercontinental.

• Over 20 years of experience in hematology
• Established therapeutic apheresis and bone marrow transplantation centers
• Published 19+ international articles on hematology
• Active member of domestic hematology associations
• Educator for young hematologists